Reviewing Friday’s Top Picks
iBio, Inc. IBIO
The number one mover from our Friday morning report was undoubtedly IBIO. Our recent observation that increasing concerns over the presence of the Ebola virus on American soil would drive related stocks paid off in spades.
IBIO was among those to get a huge boost on unconfirmed reports that it would aid in government efforts to speed production of the ZMapp experimental Ebola treatment.
The stock would see a low of .89 near the beginning of the session, and ended up running extremely hard into the close, reaching a high of 1.57. That equals out to an intraday surge of 76% but our total possible gains didn’t stop there. The stock continues to roll this morning, having hit a high of 2.76 in the premarket and pushing the total amount of the increase we’ve seen on IBIO since Friday morning to an impressive 210%
Alpha Pro Tech Ltd. APT
Like IBIO, APT was also affected by Ebola fears on Friday, and traded in a less extreme but similar pattern. After seeing a morning low of 5.72, the stock pushed the envelope into the close, reaching a peak of 7.43 for a 30% intraday gain. It is also gapping up bigtime today, with a premarket high of 9.25, which marks a 62% move up from Friday morning’s low.
Doral Financial Corp. DRL
Some of our more seasoned subscribers will certainly remember our coverage of DRL this year. We were waiting to get word on the company’s tax suit against the Puerto Rican governement, and Friday following market close, it was announced that the court has ruled in favor of Doral, which will be due the disputed-over sum of $229M.
As a result of this untraded-upon news, the stock is gapping up like crazy today, to the tune of a 9.46 premarket high, up well over 100% above the low we observed following our initial alert on DRL this summer.
We’ll probably see some selling pressure from profit taking in a situation like this, so we’ll be on the lookout for a potential dip-and-rip scenario to kick off the week.
AHPI, HEB, NSPH, SMED, FOMX, OBCI,